Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

BioResearch is following  new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic, published by  The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA). Please click below link for details.

Go back

News

Open Recruitment to new study

We have started new study with testosterone for healthy Volunteers or Patients with testosterone deficiency.

Read more …

FIM study

We have just succesfully finished First in Man study with psychoactive substance.

Read more …

Christmas wishes

To all our Sponsors, partners, subcontractors and co-workers we would like to wish joyful Christmas and a Happy New Year!

Read more …

Participation in NCBiR project

As a Clinical Site we have won a tender for an innovative 1st phase project co-funded by NCBiR.

Read more …

GMP Specialist

Ms Dorota Osińska, M.Sc., Pharmacist, QP and experienced auditor, joined BioResearch and started GMP certification process.

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2025 © Bio Research Group. All rights reserved.

 

scroll to top ▲